FDA Flags Concerns at Akorn ' s Amityville Plant, Shares Slip FDA Flags Concerns at Akorn ' s Amityville Plant, Shares Slip

Generic drugmaker Akorn Inc said on Thursday the U.S. Food and Drug Administration had raised concerns about its manufacturing plant in Amityville, New York, that included a lack of records on the maintenance and cleaning of equipment.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Medscape Today News Source Type: news